775 search results for “cancer” in the Public website
-
Peter Bouwman
Science
-
Elizabeth (Liesbeth) de Lange
Science
-
Research
The current projects of the Molecular Physiology group focus on proteins of the endocannabinoid system, kinases and antibacterial targets. MSc- and BSc-students can contact Jessica van Krimpen-Kraaijenoord to apply for research internships.
-
Bio-organic Synthesis
The research in the Biosyn group is focused on the design, synthesis and function of the four major types of biomolecules: nucleic acids, carbohydrates, peptides and lipids and hybrid structures thereof. These biomolecules and their derivatives are used in drug discovery and chemical biology, to develop…
-
Ariane Briegel: 'AI literally opens new worlds for the life sciences'
Bacteria caught red-handed, deeply frozen just as they were about to cause Lyme’s disease. Ariane Briegel is wildly enthusiastic about the wonders she observes thanks to three elements: a freezing technique, a camera-equipped microscope, and AI. ‘It’s fascinating. Every single cell is different.’
-
Kinetics for Drug Discovery: a Case for the Adenosine A3 receptor
Supervisor: Lizi Xia
-
Determining the kinetic profile of ENT1 inhibitors
Supervisor: Anna Vlachodimou
-
Molecular Pharmacology
In this research group, headed by Laura Heitman, novel receptor concepts in drug discovery are studied, aiming to increase the effectivity of medicines. Many drugs act via so-called G protein-coupled receptors (GPCRs) and therefore our research is mainly focused on understanding and improving drug-receptor…
-
Bioorthogonal deprotection strategy to study T-cell activation and cross- presentation
Cytotoxic T-cells (CTLs) are involved in the clearance of viruses and killing of tumor cells.
-
John van Noort Lab - Chromatin Dynamics
Chromatin is an ubiquitous protein-DNA complex that forms the structural basis of DNA condensation in all eukaryotic organisms.
-
Predictive pharmacology
The aim of this research area is to be able to predict human drug response on the basis of mathematical models that are developed using preclinical experiments and prior knowledge.
-
Topological decoding of biomolecular fold complexity
Biological polymers, including proteins and the genome, undergo folding processes crucial for their proper functioning. Even slight changes in the folding structure of these biopolymers can have significant implications, leading to the development of various pathological conditions, such as neurodegenerative…
-
Stefan Semrau Lab - Quantitative Single-Cell Biology
We study cell-fate decision-making using embryonic stem cells as a model system. Stem cells integrate a large number of cues to direct their development into a great variety of cell types.
-
Discovery of FLT3 inhibitors for the treatment of acute myeloid leukemia
The disease acute myeloid leukemia (AML) is characterized by fast progression and low survival rates.
-
Professor Ewa Snaar-Jagalska appointed professor in the field of cellular tumor biology
From the 11th of May Ewa Snaar-Jagalska has been appointed Professor in the field of cellular tumor biology within the Faculty of Science at the Institute of Biology Leiden. Her research focuses on the cellular tumor biology and human cancer modeling in zebrafish
-
Regulation of signal transduction pathways by hypoxia in breast cancer subtypes
PhD defence
-
Computational modeling of pharmacokinetics and tumor dynamics to guide anti-cancer treatment
PhD defence
-
Photodynamic therapy-based combinations with immunotherapy in colon cancer treatment
PhD defence
-
evaluations of nanocarriers to improve the effectiveness of colorectal cancer treatment
PhD defence
-
Discovering and developing drugs
Improving healthcare with our scientific discoveries: that is the goal of pharmaceutical research at Leiden University. And there’s a lot involved in that. Our research starts with the discovery of the effect achieved by a particular substance, and sometimes continues all the way through to the development…
-
Vascular and Regenerative Medicine
Methods of treatment for chronic illnesses are limited. Doctors and researchers at Leiden University Medical Center (LUMC) and Leiden University are working on new therapies as an alternative for organ transplants. The goal is to cure the illnesses by restoring organs to their original function. Stem…
-
Awards and Grants 2017
An overview of awards and prizes granted to our staff and students in 2017, as well as special appointments and royal distinctions.
-
Hit and Lead Optimization
The goal of hit and lead optimization is to optimize suitable chemical starting points that can modulate a drug target. The methods and technologies used are similar to those in Hit Discovery, but once the compound has shown activity in an animal model, it moves from 'hit' to 'lead.'
-
Participants
The CIGR comprises research groups from the Institute of Biology Leiden (IBL), the Leiden Institute of Chemistry (LIC), the Leiden Academic Centre for Drug Research (LACDR) and the Leiden Institue of Physics (LION).
-
Leiden University Medical Center
The Leiden University Medical Center (LUMC) is committed to improving healthcare and the health of individuals. The LUMC staff put this mission into practice on a daily basis with their leading research, cutting-edge teaching and optimal, innovative healthcare.
-
Research
Research at the BIOSYN group is comprised of the following research themes:
-
PhD Theses
A full overview of MCBIM PhD theses.
-
Institute of Biology
Nature is a never-ending source of inspiration for the researchers at the Institute of Biology Leiden (IBL). Based on a better fundamental understanding of nature, they are able to seek solutions in the area of health and biodiversity. The theme of IBL is ‘Harnessing biodiversity for health.’
-
Computational Drug Discovery
Research in this group, headed by Gerard van Westen, focusses on computational methods integrated in different parts of the drug discovery process. More specifically, topics include innovative treatments for cancer, selectivity modeling, translational research, allosteric modulation, drug resistance…
-
Four NWO Open Competition grants for Leiden researchers
Four researchers from Leiden University have been awarded NWO Open Competition grants in the Science domain. This is for research into subjects such as immune cells in tumours, antibiotic resistance and magnetic semiconductors.
-
Text-mining real-world data to evaluate systemic anti-cancer therapy
PhD defence
-
Colorectal cancer screening for average- and high-risk individuals Beyond one-size-fits-all
PhD defence
-
The T cell-myeloid axis in the success and failure of cancer immunotherapy
PhD defence
-
Systems biology as a compass to understand cancer-immune interactions in humans
PhD defence
-
BRCA1-associated breast cancer: finding new weapons for an old villain
PhD defence
-
Supporting women with breast cancer in making an informed decision about immediate breast reconstruction
PhD defence
-
Pancreatic cancer: Chasing the light at the end of the tunnel
PhD defence
-
The role of the Bone Morphogenetic Protein Pathway in Colorectal Cancer
PhD defence
-
The impact of one: single cell analysis of T cell states in human cancer
PhD defence
-
Disrupting the transcriptional machinery to combat triple-negative breast cancer
PhD defence
-
Light therapy for cancer-related fatigue in (non-)Hodgkin Lymphoma Survivors
PhD defence
-
Sexual Health Care in Prostate Cancer for Men and their Partners
PhD defence
-
pharmacogenetics of systemic and intraperitoneal chemotherapy in colorectal cancer
PhD defence
-
Partial Breast Irradiation in elderly patients with early-stage breast cancer
PhD defence
-
Cancer-induced somatic mutations in G protein-coupled receptors
PhD defence
-
Immunosuppression in breast cancer: a closer look at regulatory T cells
PhD defence
-
Genomic driven treatment and drug rediscovery in patients with advanced cancer
PhD defence
-
Molecular imaging of pancreatic and rectal cancer - Towards optimized detection and response prediction
PhD defence
-
Untangling the immune landscape of colorectal cancer by in situ multiplex immunophenotyping
PhD defence
-
the response to immunotherapy in patients with non- small cell lung cancer
PhD defence